Micron completes successful Phase 1b trial for UK Biotech company
Full details are available here
Stay up-to-date with our latest breakthroughs, advancements, and success stories.
Full details are available here
Thank you to all the visitors to Booth 11 who made it such a busy and stimulating meeting to attend.
Read MoreWe are delighted to announce that Chris Cooke has joined Micron as CFO for the whole group
Consultancy and study design for a new, rapid antimicrobial susceptibility testing system
Upgraded ATLAS AMR database released (atlas-surveillance.com) with nearly 1 million records included, covering 20 years of data collection
LogicTrials completes move to new, expanded facility in Pretoria, serving South Africa and beyond for depot handling of clinical trial and logistic materials
Phase II study in hospitalised pneumonia expanding in 2025
Innovative RWE study on hospital infection (CODAR), collecting data directly from EHRs on >8000 patients in 5 countries, completed successfully
Multi-country Phase Ib study in patients with chronic low back pain and vertebral oedema completes recruitment
Phase II study in multidrug-resistant tuberculosis (MDR-TB) in South Africa completed successfully, with 122 patients recruited
109B Lancaster Way Business Park
Ely, Cambridgeshire
England, United Kingdom
12022 Blue Valley Parkway, Overland Park
Kansas 66213, United States of America
Route 21 Corporate Park
5 Regency Drive, Building C
Irene, South Africa
Harju maakond, Tallinn, Kesklinna linnaosa
Viru väljak 2, Tallinn 10111, Estonia
9 Regency Drive, Building B, Route 21 Corporate Park
Irene, 0157, South Africa